Antibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66059-1-Ig - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#66059-1-Ig, RRID:AB_11042326
- Product name
- RBM15 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated RBM15 antibody (Cat. #66059-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 4A1A4
- Vial size
- 20ul, 150ul
Submitted references RNA-binding motif protein 15 promotes gastric cancer growth and drug resistance via USP10-mediated deubiquitination and stabilization of nuclear NRF2.
RBM15/YTHDF2-mediated m6A modification of HTR1D exacerbates hypoxia-induced dysfunction in trophoblast cells in preeclampsia.
Cuproptosis- and m6A-related lncRNA prognostic signature for breast cancer, in which Z68871.1 contributes to triple-negative breast cancer progression.
RBM15 mediates m6A methylation modification of FOSB mRNA to promote dysfunction of trophoblast cells-a potential link to preeclampsia.
M6A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC.
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1.
A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.
The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism.
The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.
Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.
The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing.
Ma Z, Xu Z, Xu J, Chen C, Niu W, Wang Y, Qian Y, Zhang X, Yang M, Stefan SM, Gan L, Wang S, Wang B
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2026 May;86:101376
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2026 May;86:101376
RBM15/YTHDF2-mediated m6A modification of HTR1D exacerbates hypoxia-induced dysfunction in trophoblast cells in preeclampsia.
Yu B, Gong H, Zhang S, Zhao M, Shi Y
Naunyn-Schmiedeberg's archives of pharmacology 2026 Jan;399(1):1079-1090
Naunyn-Schmiedeberg's archives of pharmacology 2026 Jan;399(1):1079-1090
Cuproptosis- and m6A-related lncRNA prognostic signature for breast cancer, in which Z68871.1 contributes to triple-negative breast cancer progression.
Zhang Z, Gao Z, Huang Q, Ling Z, Zhang L, Li M, Xu Y, Liu M
International journal of biological macromolecules 2025 Sep;321(Pt 2):146321
International journal of biological macromolecules 2025 Sep;321(Pt 2):146321
RBM15 mediates m6A methylation modification of FOSB mRNA to promote dysfunction of trophoblast cells-a potential link to preeclampsia.
Li Y, Li F, Gao Q
Hereditas 2025 Nov 21;162(1):241
Hereditas 2025 Nov 21;162(1):241
M6A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC.
Zhi Y, Liu S, Chang X, Guan W, Li R, Liu Q, Chen J, Ling J, Zhao X, Liu A, Chen J, Zhang X, Huang Y
Cancer control : journal of the Moffitt Cancer Center 2025 Jan-Dec;32:10732748251342685
Cancer control : journal of the Moffitt Cancer Center 2025 Jan-Dec;32:10732748251342685
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1.
Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, Mu Y, Shen W, Tong J, Chen H, Hu Z, Zhang J, Qiu K, Chen W, Cheng X, Xu G
Oncogene 2025 Feb;44(5):307-321
Oncogene 2025 Feb;44(5):307-321
A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.
Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J, Guo M, Fan D, Yu C, Qin D, Zhou X, Wu A
Theranostics 2024;14(16):6161-6184
Theranostics 2024;14(16):6161-6184
The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism.
Park SH, Ju JS, Woo H, Yun HJ, Lee SB, Kim SH, Győrffy B, Kim EJ, Kim H, Han HD, Eyun SI, Lee JH, Park YY
Experimental & molecular medicine 2024 Jun;56(6):1373-1387
Experimental & molecular medicine 2024 Jun;56(6):1373-1387
The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.
Li Y, Zhang X, Cai J, Ren L, Liu B, Wu M, Lu W, Li R, Zhang C, Huang C, Tong J, Liu A, Zheng Y, Ren D, Guo Y, Huang Y
The journal of gene medicine 2022 Feb;24(2):e3397
The journal of gene medicine 2022 Feb;24(2):e3397
Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.
Guo Y, Liu Y, Zhao S, Xu W, Li Y, Zhao P, Wang D, Cheng H, Ke Y, Zhang X
Nature communications 2021 Dec 7;12(1):7094
Nature communications 2021 Dec 7;12(1):7094
The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.
Tran NT, Su H, Khodadadi-Jamayran A, Lin S, Zhang L, Zhou D, Pawlik KM, Townes TM, Chen Y, Mulloy JC, Zhao X
EMBO reports 2016 Jun;17(6):887-900
EMBO reports 2016 Jun;17(6):887-900
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing.
Zhang L, Tran NT, Su H, Wang R, Lu Y, Tang H, Aoyagi S, Guo A, Khodadadi-Jamayran A, Zhou D, Qian K, Hricik T, Côté J, Han X, Zhou W, Laha S, Abdel-Wahab O, Levine RL, Raffel G, Liu Y, Chen D, Li H, Townes T, Wang H, Deng H, Zheng YG, Leslie C, Luo M, Zhao X
eLife 2015 Nov 17;4
eLife 2015 Nov 17;4
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 66059-1-Ig(RBM15 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of Hela cells, using RBM15 antibody 66059-1-lg at 1:25 dilution and Rhodamine-labeled goat anti-mouse IgG (red).
- Sample type
- cell line